Top Markets
Coin of the day
Vycor Medical, Inc. Vycor Medical, Inc.

Vycor Medical, Inc.

VYCO
株式のランク #36814
Vycor Medical, Inc. (VMI) is dedicated to the creation, development, and... Vycor Medical, Inc. (VMI) is dedicated to the creation, development, and commercialization of neurological medical devices and therapeutic solutions, operating in both the United States and European markets. The company's operations are divided into two primary business units. The Vycor Medical division specializes in neurosurgical instrumentation, providing devices such as the ViewSite Brain Access System—a critical retraction and access tool used in brain and spine surgeries. Conversely, the NovaVision segment delivers advanced, non-invasive, computer-based rehabilitation programs aimed at helping individuals with vision impairments resulting from strokes or other brain injuries. VMI has also established a strategic license and transition agreement with HelferApp GmbH, authorizing HelferApp to distribute NovaVision's products and therapies to patients and healthcare providers in Austria and Switzerland. The company's main clientele consists of hospitals and various medical professionals. Established in 2005, Vycor Medical, Inc. is headquartered in Boca Raton, Florida, and functions as a subsidiary of Fountainhead Capital Management Limited.
株価
$0.069
最終同期: 2026-08-13
時価総額
$2.30M
変化(1日)
0.00%
変化(1年)
-46.92%
US
取引 Vycor Medical, Inc. (VYCO)

カテゴリー

Vycor Medical, Inc.(VYCO)の営業利益率
2026 時点の営業利益率 TTM: 0.00%
Vycor Medical, Inc. の最新の財務報告と株価によると、現在の営業利益率(TTM)は 0.00% です。2026 年末時点では 0.00% でした。
Vycor Medical, Inc. の営業利益率の履歴(2026 から 2026)
各年末の営業利益率
営業利益率 変化
提供された日付のデータは十分ではありません。
同業他社の営業利益率
企業 営業利益率 営業利益率の差
17.03% -
US
22.03% -
US
17.86% -
IE
21.46% -
US
28.09% -
US
企業の営業利益率とは?
営業利益率は、企業の収益性を評価するための重要な指標です。高い営業利益率は一般的に良いとされており、企業が製品やサービスをその生産コストよりもはるかに高く販売できていることを示します。営業利益率は、企業の利益を売上高で割ることで計算されます。